4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and ...
Leadership
John F. Milligan Ph.D.
Executive Chairman
David H. Kirn M.D.Founder
Co-Founder, President, CEO & Director
Kristian Humer M.B.A.
CFO and Principal Financial & Accounting Officer
Fariborz Kamal Ph.D.
Chief Technical Advisor
Theresa JankeFounder
Co-Founder & Chief of Staff
Julian Pei
Head of Investor Relations & Corporate Finance
Katy Barglow Ph.D.
Chief Technical Officer
Scott P. Bizily J.D., Ph.D.
Chief Legal Officer & Corporate Secretary
An Song Ph.D.
Chief Translational Medicine Advisor
Noriyuki Kasahara M.D., Ph.D.
Chief Scientific Advisor & Member of Scientific Advisory Board
